MCPH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.11175521513951E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.18070000443282E-08 |
Normal-vs-Stage2 |
9.991100E-04 |
Normal-vs-Stage3 |
4.55191440096314E-15 |
Normal-vs-Stage4 |
4.03943545279617E-12 |
Stage1-vs-Stage2 |
7.985800E-01 |
Stage1-vs-Stage3 |
8.13820000000742E-05 |
Stage1-vs-Stage4 |
8.963400E-04 |
Stage2-vs-Stage3 |
1.740260E-02 |
Stage2-vs-Stage4 |
2.584100E-02 |
Stage3-vs-Stage4 |
9.561800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.37030387037385E-11 |
Normal-vs-AfricanAmerican |
6.48309994577545E-09 |
Normal-vs-Asian |
8.216000E-03 |
Caucasian-vs-AfricanAmerican |
2.781800E-01 |
Caucasian-vs-Asian |
8.471000E-01 |
AfricanAmerican-vs-Asian |
8.129200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.72806213782906E-12 |
Normal-vs-Female |
3.47689999014023E-09 |
Male-vs-Female |
2.876800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.6531999999998E-05 |
Normal-vs-Age(41-60Yrs) |
1.89169999664784E-08 |
Normal-vs-Age(61-80Yrs) |
1.67055258515347E-12 |
Normal-vs-Age(81-100Yrs) |
1.423820E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.361200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.008000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.822200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.307900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.796200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.871400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.547600E-01 |
Normal-vs-Grade 2 |
1.02379999999958E-06 |
Normal-vs-Grade 3 |
1.62503344114384E-12 |
Normal-vs-Grade 4 |
1.65711888655551E-12 |
Grade 1-vs-Grade 2 |
7.607700E-02 |
Grade 1-vs-Grade 3 |
3.220300E-04 |
Grade 1-vs-Grade 4 |
9.80710000000329E-05 |
Grade 2-vs-Grade 3 |
1.757510E-04 |
Grade 2-vs-Grade 4 |
1.72932999999986E-05 |
Grade 3-vs-Grade 4 |
3.175600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.04280000004609E-06 |
Normal-vs-ccB subtype |
8.20860046601979E-11 |
ccA subtype-vs-ccB subtype |
1.476540E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.08749947619935E-10 |
Normal-vs-N1 |
1.95720999999205E-05 |
N0-vs-N1 |
1.946800E-01 |
|
|